Dyax Corp Articles

Dyax partners with CVie Therapeutics for Kalbitor in Greater China

7 February 2013

Milestone payment for Ardea from Bayer, which executes license with Dyax

31 May 2012

Dyax and Sigma Tau unit pull EU filing on Kalbitor

15 November 2011

Dyax expands Sigma-Tau territories for Kalbitor for $7M upfront

1 June 2011

Dyax licenses DX-88 (ecallantide) to CMIC in Japan in $106 million deal

1 October 2010

Dyax licenses HAE drug Kalbitor rights to Sigma-Tau for a potential $105 million

22 June 2010

Showing 1-6 of 6 articles

Go to beginningPrevious
  • 1
NextGo to end